Biden Administration Plans to Offer Updated Booster Shots in September
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
With reformulated shots from Pfizer and Moderna on the horizon, the F.D.A. has decided that Americans under 50 should wait to receive second boosters.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
Vaccines from Pfizer and its partner BioNTech are already been available for Americans 6 and older, and Moderna’s vaccines have been approved for adults.
As eagerly anticipated as the shots are for some parents, the F.D.A. advisory committee’s decisions are just one step in a process federal regulators must […]
As eagerly anticipated as the shots are for some parents, the committee’s meeting is just one step in a process federal regulators must follow before […]
Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest […]
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
The antiviral pills, plentiful in the United States, are scarce overseas. Health groups and the White House want to expand access but face obstacles that […]
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected soon.
Once again, a dysfunctional health care system has hindered our pandemic response.
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune […]
The plan will offer people 65 and older — and possibly some younger adults — the option of another booster, in case infections surge again […]
The company said the vaccine produced a strong immune response in children younger than 6, but proved only about 40 percent effective in preventing symptomatic […]
The move follows recalls of other medications found to have higher levels of potential carcinogens.
The move follows recalls of other medications found to have higher levels of potential carcinogens.
The move follows recalls of other medications found to have higher levels of potential carcinogens.
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
No está claro si tres dosis de la vacuna Pfizer-BioNTech protegerán adecuadamente a los niños. Pero es posible que la FDA autorice las primeras dos […]
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.
The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or clinic.
Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.
Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.
Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.
Scarce supplies and surging Covid cases have caused health officials, hospitals, doctors and patients to scramble for pills and infusions.
President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.
President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.
President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.
President Biden announced that the United States government doubled its order for Pfizer’s Covid pills, bringing the total order to 20 million treatment courses.
President Biden announced that the United States government doubled its order for Pfizer’s Covid pills, bringing the total order to 20 million treatment courses.
President Biden announced that the United States government doubled its order for Pfizer’s Covid pills, bringing the total order to 20 million treatment courses.
Following the F.D.A.’s lead, the agency also recommended third shots after four weeks for some immunocompromised children 5 to 11.
Following the F.D.A.’s lead, the agency also recommended third shots after four weeks for some immunocompromised children 5 to 11.
Regulators will also allow even younger children with immune deficiencies to get an extra shot.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
It is the first pill approved in the nation to treat symptoms of the coronavirus.
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The F.D.A. said the drug should be prescribed mainly when other treatments were “not accessible or clinically appropriate.”
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The treatment, called Paxlovid, is likely to work against Omicron and could be available in the United States before the end of the year.
The company said the pill, Paxlovid, reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of […]
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Pfizer and BioNTech say booster shots offer strong protection against Omicron.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck y Pfizer están por presentar sus pastillas de prescripción para tratar la COVID-19. Vienen más fármacos en camino.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
The pills must be given early in the course of infection, which means access to timely, accurate test results will be crucial.
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by […]
The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
The Biden administration will spend billions of dollars on a new plan to combat the pandemic, investing in antiviral pills, rapid tests and manufacturing.
. The request is for use in unvaccinated, high risk patients. But the regulator could authorize it for broader use.
. The request is for use in unvaccinated, high risk patients. But the regulator could authorize it for broader use.
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
Regulators are set to clear extra doses of Pfizer-BioNTech’s vaccine as soon as Thursday, after states began expanding eligibility on their own.
. The request is for use in unvaccinated, high risk patients. But the regulator could authorize it for broader use.
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the […]
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard […]
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard […]
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard […]
Pfizer on Tuesday asked the Food and Drug Administration to authorize its pill for unvaccinated people.
The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid, and works differently from the first.
The company announced a deal that could help significantly expand access to the Covid-19 treatment, but the agreement excludes a number of countries hit hard […]
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
The Secretary of State called for rich countries, pharmaceutical companies and others to “step up.”
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Pfizer’s is the second pill to show effectiveness against Covid-19, and it is the first purpose-built to attack the virus that causes the disease.
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
Many health advocates say a key solution is to make the shots in the regions that still don’t have them. I wanted to know whether […]
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current […]
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current […]
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current […]
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current […]
Once the experts weigh in, the Food and Drug Administration itself makes a decision and then a similar process happens at the Centers for Disease […]
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps next week, a long-awaited development that would affect 28 million children.
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
The company said that in a study, boosters cut down the number of breakthrough infections among fully vaccinated people by more than 95 percent.
La FDA podría autorizar dosis de refuerzo de vacunas diferentes de los que los estadounidenses recibieron en sus primeras dosis. Hay evidencia científica prometedora que […]
The agency will also allow vaccine recipients to pick which vaccine they want as a booster, endorsing a mix-and-match approach.
The agency will also allow vaccine recipients to pick which vaccine they want as a booster, endorsing a mix-and-match approach.
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
The F.D.A. may authorize booster shots of vaccines different from the ones that Americans originally received. The science behind the move is promising.
The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines voted on this week? This scorecard may […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines voted on this week? This scorecard may […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard […]
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
Vaccines for kids inch forward.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The agency has promised to move quickly on the request and has tentatively scheduled a meeting at the end of the month to consider it.
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
The findings, which also document a waning of protection against infection, come as officials debate the necessity and timing of booster shots.
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
Readers discuss the government’s handling of the issue. Also: Abortion stories; criminal justice reform; voice recognition; extinct species.
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
Moderna accepted $2.5 billion in taxpayer money to develop its Covid-19 vaccine. But officials in the U.S. and overseas are having trouble persuading the company […]
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
The study came out hours before an expert panel of advisers to the F.D.A. voted not to recommend booster shots.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on […]
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.
Tenemos una guía con las recomendaciones y opiniones de los expertos en salud para despejar tus dudas.
Tenemos una guía con las recomendaciones y opiniones de los expertos en salud para despejar tus dudas
Health experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks.
Health experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks.
Johnson & Johnson is sending shots from South Africa to other parts of the world. African countries are waiting for most of the doses they’ve […]
Boosters may not be necessary yet, many experts say, and the pursuit of additional shots raises ethical questions.
The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.
The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.
Boosters may not be necessary yet, many experts say, and the pursuit of additional shots raises ethical questions.
The F.D.A. wants Pfizer and Moderna to increase the number of 5- to 11-year-olds who participate in trials of their coronavirus vaccines to ensure there […]
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Muchos de los que recibieron la vacuna pueden necesitar refuerzos, dijeron los autores. Pero las autoridades sanitarias federales no recomiendan segundas dosis.
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
The Delta variant has accelerated conversations about introducing booster doses of coronavirus vaccines.
The Delta variant has accelerated conversations about introducing booster doses of coronavirus vaccines.
Boosters may make it to market whether they are critical for vaccinated people or not.
Boosters may make it to market whether they are critical for vaccinated people or not.
After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
The Pfizer and Moderna vaccines are safe and effective. Full approval from the F.D.A. will help stop the spread of Covid-19.
The Pfizer and Moderna vaccines are safe and effective. Full approval from the F.D.A. will help stop the spread of Covid-19.
An advisory body approved following up AstraZeneca shots with either Pfizer-BioNTech or Moderna vaccines.
An advisory body approved following up AstraZeneca shots with either Pfizer-BioNTech or Moderna vaccines.
An advisory body approved following up AstraZeneca shots with either Pfizer-BioNTech or Moderna vaccines.
An advisory body approved following up AstraZeneca shots with either Pfizer-BioNTech or Moderna vaccines.
The United States began vaccinating children in that age group earlier this month.
The United States began vaccinating children in that age group earlier this month.
The United States began vaccinating children in that age group earlier this month.
Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. ¿Tiene solución?
Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. ¿Tiene solución?
Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. ¿Tiene solución?
Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. ¿Tiene solución?
Es un inmenso problema: no hay suficientes vacunas y aún menos para los países pobres. ¿Tiene solución?
President Biden’s pledge to ship out doses that could have been used domestically was a step toward a global campaign, but activists say much more […]
President Biden’s pledge to ship out doses that could have been used domestically was a step toward a global campaign, but activists say much more […]
President Biden’s pledge to ship out doses that could have been used domestically was a step toward a global campaign, but activists say much more […]
President Biden’s pledge to ship out doses that could have been used domestically was a step toward a global campaign, but activists say much more […]
President Biden’s pledge to ship out doses that could have been used domestically was a step toward a global campaign, but activists say much more […]
When President Biden joined a push to set aside patents for Covid shots, he entered a roiling debate over how to ensure poor countries get […]
When President Biden joined a push to set aside patents for Covid shots, he entered a roiling debate over how to ensure poor countries get […]
When President Biden joined a push to set aside patents for Covid shots, he entered a roiling debate over how to ensure poor countries get […]
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
The shots may allow millions of youngsters to get back to school, camps, sleepovers and hangouts with friends.
The vaccine has been used under an emergency authorization since December. A decision by the Food and Drug Administration could take months.
The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in […]
The vaccine has been used under an emergency authorization since December. A decision by the Food and Drug Administration could take months.
La pandemia se ha transformado en entretenimiento en Estados Unidos. Es una sociopatía supercapitalista y, también, prueba de que la experiencia pandémica ha sido deformada […]
La pandemia se ha transformado en entretenimiento en Estados Unidos. Es una sociopatía supercapitalista y, también, prueba de que la experiencia pandémica ha sido deformada […]
The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in […]
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
The U.S. vaccination campaign will soon expand to millions more people, but public health experts say the move raises complicated questions about supply and access.
The U.S. vaccination campaign will soon expand to millions more people, but public health experts say the move raises complicated questions about supply and access.
The company said it also plans to apply this month for full F.D.A. approval — not just emergency authorization — for the vaccine’s use in […]
The company said its vaccine generated $3.5 billion in revenue in the first three months of this year.
President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.
President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.
President Biden and drugmakers are facing demands from liberal activists and global leaders to suspend intellectual property rights on the vaccines as the pandemic surges.
The U.S. vaccination campaign will soon expand to millions more people, but public health experts say the move raises complicated questions about supply and access.
It feels very American to turn the vaccine rollout into a branding spectacle rooted in the worship of pharmaceutical companies.
The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination […]
The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination […]
Nearly 8 percent of those who got initial Pfizer or Moderna shots missed their second doses. State officials want to prevent the numbers from rising.
The European Union is about to sign a deal for 1.8 billion doses of the Pfizer-BioNTech vaccine after a dispute with AstraZeneca derailed its vaccination […]
It feels very American to turn the vaccine rollout into a branding spectacle rooted in the worship of pharmaceutical companies.
Nearly 8 percent of those who got initial Pfizer or Moderna shots missed their second doses. State officials want to prevent the numbers from rising.
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for […]
After an early focus on AstraZeneca and months of turmoil, the European Union is pivoting away from the company’s vaccine. It has reached agreement for […]
Copyright © 2024 | WordPress Theme by MH Themes